GRAIL, Inc. Share Price & Technical Analysis
GRAL · $60.90 (-1.01%)
Healthcare / Diagnostics & Research
$60.90
-1.01%
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides devel…
Price chart
Seasonality
Jun has 3 positive and 0 negative years (last 3 years shown)
4% return in Jun, 22% avg return in past 3 year Jun month.
13% return in 2026, 146% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 12% | -46% | 5% | 5% | 33% | 4% | – | – | – | – | – | – | 13% |
| 25 | 70% | 35% | -37% | 36% | 9% | 34% | -32% | 0% | 86% | 56% | 23% | -20% | 261% |
| 24 | – | – | – | – | – | 11% | 2% | -11% | -1% | -1% | 29% | 2% | 31% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.65B
P/E ratio
—
52W high
$118.8
52W low
$29.95
Volume
5,45,534
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹36,480
Abbott Laboratories Cede…
₹34,460
Eli Lilly And Company Ce…
₹30,560
Unitedhealth Group Inc C…
₹18,330
Elevance Health Inc
₹7,255
Frequently asked questions
- What is GRAIL, Inc. share price today?
- GRAIL, Inc. (GRAL) last traded around $60.90 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does GRAL have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GRAL. Download the app for real-time alerts.
- How can I analyze GRAIL, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.